A case of HER-2-positive recurrent breast cancer showing a clinically complete response to trastuzumab-containing chemotherapy after primary treatment of triple-negative breast cancer

Autor: Haruta Rumi, Masumoto Norio, Emi Akiko, Sasada Tatsunari, Kajitani Keiko, Kobayashi Yoshie, Kadoya Takayuki, Shigematsu Hideo, Kataoka Tsuyoshi, Oda Miyo, Arihiro Kouji, Okada Morihito
Jazyk: angličtina
Rok vydání: 2011
Předmět:
Zdroj: World Journal of Surgical Oncology, Vol 9, Iss 1, p 146 (2011)
Druh dokumentu: article
ISSN: 1477-7819
DOI: 10.1186/1477-7819-9-146
Popis: Abstract We report a case of HER-2-positive recurrent breast cancer showing a clinically complete response to trastuzumab-containing chemotherapy 6 years after primary treatment of triple-negative breast cancer. The primary tumor was negative for HER-2 as determined by immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) (1+, and ratio, 1.1), but examination of the recurrent lymph node metastasis showed positivity for HER-2 by FISH (ratio, 5.2). No lesions were detected in either her left breast or in other organs, and the patient was diagnosed as having HER-2-positive recurrent disease. Combination chemotherapy using weekly paclitaxel and trastuzumab was initiated, and a clinically complete response was achieved. This report suggests the benefit of routine evaluation of HER-2 status in recurrent breast cancer with the introduction of HER-2-targeting agents.
Databáze: Directory of Open Access Journals